Molecular Cytogenetic Profiles of Novel and Established Human Anaplastic Thyroid Carcinoma Models
- 1 April 2007
- journal article
- research article
- Published by Mary Ann Liebert Inc in Thyroid®
- Vol. 17 (4) , 289-301
- https://doi.org/10.1089/thy.2006.0246
Abstract
In this study we present two novel anaplastic thyroid carcinoma (ATC) lines (HTh 104 and HTh 112) and further characterize six frequently used ATC lines (HTh 7, HTh 74, HTh 83, C 643, KAT-4, and SW 1736). Three of the lines carried a heterozygous BRAF mutation V600E, which is in line with reports of BRAF mutations in primary ATC and papillary thyroid cancer. Several nonrandom breakpoints were identified by spectral karyotyping (SKY) and G-banding in these lines including the novel 1p36 and 17q24-25 as well as 3p21-22 and 15q26 that are also implicated in well-differentiated thyroid cancers. Comparative genomic hybridization showed frequent gain of 20q, including the UBCH10 gene in 20q13.12, which was further confirmed by array-comparative genomic hybridization and fluorescence in situ hybridization analyses. Our results concur with previous studies in both primary tumors and cell lines, indicating that gain of chromosome 20 is important in the pathogenesis of ATC and/or progression of differentiated thyroid cancers to ATC.Keywords
This publication has 33 references indexed in Scilit:
- Pathogenetic mechanisms in thyroid follicular-cell neoplasiaNature Reviews Cancer, 2006
- BRAF mutation in thyroid cancerEndocrine-Related Cancer, 2005
- Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancerJournal of Clinical Investigation, 2005
- Genetic Alterations Involved in the Transition from Well-Differentiated to Poorly Differentiated and Anaplastic Thyroid CarcinomasEndocrine Pathology, 2004
- Silencing of the PTEN tumor‐suppressor gene in anaplastic thyroid cancerGenes, Chromosomes and Cancer, 2002
- Collagen type I expression in experimental anaplastic thyroid carcinoma: Regulation and relevance for tumorigenicityInternational Journal of Cancer, 2001
- Anaplastic thyroid carcinoma: Current diagnosis and treatmentAnnals of Oncology, 2000
- Differential Nuclear and Cytoplasmic Expression of PTEN in Normal Thyroid Tissue, and Benign and Malignant Epithelial Thyroid TumorsThe American Journal of Pathology, 2000
- Antineoplastic activity of taxol against human anaplastic thyroid carcinoma cell lines in vitro and in vivoJournal of Clinical Endocrinology & Metabolism, 1996
- Coexpression of Functionally Active Receptors for Thyrotropin and Platelet-Derived Growth Factor in Human Thyroid Carcinoma Cells*Endocrinology, 1991